Literature DB >> 17505977

NeuroAIDS in Brazil.

Ronald J Ellis1, Jeymohan Joseph, Ségio Montiero de Almeida.   

Abstract

Brazil has the largest number of HIV cases of any single country in Latin America - over 600,000. Recently, investigators have begun to characterize the extent of neurological morbidity due to HIV in this country. During 2005 and 2006, the U.S. National Institute of Mental Health cosponsored two meetings of experts aimed at summarizing existing knowledge of HIV and its neurological complications in Brazil. Topics addressed ranged from clinical neurobehavioral aspects to molecular biology. Experts attending the meeting considered fruitful directions for future research.

Mesh:

Substances:

Year:  2007        PMID: 17505977     DOI: 10.1080/13550280601132074

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  6 in total

1.  Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine.

Authors:  Udaykumar Ranga; Raj Shankarappa; Nagadenahalli B Siddappa; Lakshmi Ramakrishna; Ramalingam Nagendran; Marthandan Mahalingam; Anita Mahadevan; Narayana Jayasuryan; Parthasarathy Satishchandra; Susarla K Shankar; Vinayaka R Prasad
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism.

Authors:  Alexandre Calazans; Rodrigo Brindeiro; Patricia Brindeiro; Hugo Verli; Monica B Arruda; Luis Manuel Felipe Gonzalez; Jorge A Guimaraes; Ricardo Sobhie Diaz; Octavio A C Antunes; Amilcar Tanuri
Journal:  J Infect Dis       Date:  2005-04-28       Impact factor: 5.226

3.  A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

Authors:  Bluma Brenner; Dan Turner; Maureen Oliveira; Daniela Moisi; Mervi Detorio; Mauricio Carobene; Richard G Marlink; Jonathan Schapiro; Michel Roger; Mark A Wainberg
Journal:  AIDS       Date:  2003-01-03       Impact factor: 4.177

4.  A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil.

Authors:  Marcelo A Soares; Tulio De Oliveira; Rodrigo M Brindeiro; Ricardo S Diaz; Ester C Sabino; Luís Brigido; Ivone L Pires; Mariza G Morgado; Maria C Dantas; Draurio Barreira; Paulo R Teixeira; Sharon Cassol; Amilcar Tanuri
Journal:  AIDS       Date:  2003-01-03       Impact factor: 4.177

5.  Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.

Authors:  Nagadenahalli B Siddappa; Prashanta K Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa S Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; Vasanthapuram Ravi; Susarla K Shankar; Raj Shankarappa; Udaykumar Ranga
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

6.  Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

Authors:  Sarah C Ball; Awet Abraha; Kalonji R Collins; Andre J Marozsan; Heather Baird; Miguel E Quiñones-Mateu; Adam Penn-Nicholson; Michael Murray; Nathalie Richard; Michael Lobritz; Peter A Zimmerman; Tatsuyoshi Kawamura; Andrew Blauvelt; Eric J Arts
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

  6 in total
  2 in total

1.  Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.

Authors:  Saurabh Gupta; Jennifer E Iudicello; Chuan Shi; Scott Letendre; Adam Knight; Jianhua Li; Patricia K Riggs; Donald R Franklin; Nichole Duarte; Hua Jin; J Hampton Atkinson; Xin Yu; Zunyou Wu; Igor Grant; Robert K Heaton
Journal:  Drug Alcohol Depend       Date:  2014-01-13       Impact factor: 4.492

2.  The Effect of a Short Period of Supplementation with Glutamine Dipeptide on the Cognitive Responses after a Resistance Training Session of Women with HIV/AIDS: A Randomized Double-Blind Placebo-Controlled Crossover Study.

Authors:  Dayane Cristina de Souza; Junior Cesar da Silva; Felipe de Oliveira Matos; Alexandre Hideki Okano; Roberto Barbosa Bazotte; Ademar Avelar
Journal:  Biomed Res Int       Date:  2018-04-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.